Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 3,760 shares of common stock on March 4, 2024, with an aggregate market value of $41,815. The shares were acquired on March 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no previous sales were reported in the past three months.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 3,760 shares of common stock on March 4, 2024, with an aggregate market value of $41,815. The shares were acquired on March 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no previous sales were reported in the past three months.